A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 -
Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal, … - Science, 1994 - sciencemag.org
... Advancement of Science articles. A strong candidate for the breast and ovarian
cancer susceptibility gene BRCA1. Y Miki, J Swensen ...
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. -
DF Easton, D Ford, DT Bishop - American Journal of Human Genetics, 1995 - pubmedcentral.nih.gov
... Copyright notice. Breast and ovarian cancer incidence in BRCA1-mutation carriers. ...
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. ...
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer -
DJ Slamon, W Godolphin, LA Jones, JA Holt, SG Wong … - Science, 1989 - sciencemag.org
... Advancement of Science articles. Studies of the HER-2/neu proto-oncogene
in human breast and ovarian cancer. DJ Slamon, W Godolphin ...
… Compared With Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer. -
WP McGuire, WJ Hoskins, MF Brady, PR Kucera, EE … - Obstetrical & Gynecological Survey, 1996 - obgynsurvey.com
... Cyclophosphamide and Cisplatin Compared With Paclitaxel and Cisplatin in Patients
with Stage III and Stage IV Ovarian Cancer. ... Progress in ovarian cancer. ...
Use of proteomic patterns in serum to identify ovarian cancer -
EF Petricoin, AM Ardekani, BA Hitt, PJ Levine, VA … - The Lancet, 2002 - Elsevier
... reserved. Fast track ? Mechanisms of Disease. Use of proteomic patterns in serum
to identify ovarian cancer. ... Detection of ovarian cancer. Examples ...
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer -
SL Anzick, J Kononen, RL Walker, DO Azorsa, MM … - Science, 1997 - sciencemag.org
... [DOI: 10.1126/science.277.5328.965] Reports. AIB1, a Steroid Receptor Coactivator
Amplified in Breast and Ovarian Cancer. Sarah L. Anzick ...
PIK3CA is implicated as an oncogene in ovarian cancer -
L Shayesteh, Y Lu, WL Kuo, R Baldocchi, T Godfrey, … - Nat Genet, 1999 - palgrave-journals.com
... PIK3CA is implicated as an oncogene in ovarian cancer. ... Our observations suggest PIK3CA
is an oncogene that has an important role in ovarian cancer. Top. ...
… linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer … -
DF Easton, DT Bishop, D Ford, GP Crockford - American Journal of Human Genetics, 1993 - pubmedcentral.nih.gov
... Copyright notice. Genetic linkage analysis in familial breast and ovarian cancer:
results from 214 families. ... Six families prone to ovarian cancer. Cancer. ...
The genetic attributable risk of breast and ovarian cancer. -
EB Claus, JM Schildkraut, WD Thompson, NJ Risch - Cancer, 1996 - ncbi.nlm.nih.gov
Cancer. 1996 Jun 1;77(11):2318-24. The genetic attributable risk of breast and
ovarian cancer. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. ...
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence … -
D Ford, DF Easton, J Peto - American Journal of Human Genetics, 1995 - pubmedcentral.nih.gov
... Copyright notice. Estimates of the gene frequency of BRCA1 and its contribution
to breast and ovarian cancer incidence. ... Determinants of ovarian cancer risk. ...
Source: Google Scholar |